247 related articles for article (PubMed ID: 26084801)
21. Genome-Wide Meta-Analysis of Sciatica in Finnish Population.
Lemmelä S; Solovieva S; Shiri R; Benner C; Heliövaara M; Kettunen J; Anttila V; Ripatti S; Perola M; Seppälä I; Juonala M; Kähönen M; Salomaa V; Viikari J; Raitakari OT; Lehtimäki T; Palotie A; Viikari-Juntura E; Husgafvel-Pursiainen K
PLoS One; 2016; 11(10):e0163877. PubMed ID: 27764105
[TBL] [Abstract][Full Text] [Related]
22. A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice.
Rosemann M; Gonzalez-Vasconcellos I; Domke T; Kuosaite V; Schneider R; Kremer M; Favor J; Nathrath M; Atkinson MJ
Mol Cancer; 2014 Aug; 13():182. PubMed ID: 25092376
[TBL] [Abstract][Full Text] [Related]
23. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
24. COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death.
He M; Wang Z; Zhao J; Chen Y; Wu Y
Tumour Biol; 2014 Feb; 35(2):1297-305. PubMed ID: 24072491
[TBL] [Abstract][Full Text] [Related]
25. MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.
Xie Y; Sun W; Deng Z; Zhu X; Hu C; Cai L
Sci Rep; 2017 Oct; 7(1):13388. PubMed ID: 29042587
[TBL] [Abstract][Full Text] [Related]
26. Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcoma.
Marko TA; Shamsan GA; Edwards EN; Hazelton PE; Rathe SK; Cornax I; Overn PR; Varshney J; Diessner BJ; Moriarity BS; O'Sullivan MG; Odde DJ; Largaespada DA
Sci Rep; 2016 Dec; 6():39059. PubMed ID: 27966608
[TBL] [Abstract][Full Text] [Related]
27. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
Sun XH; Geng XL; Zhang J; Zhang C
Tumour Biol; 2015 Mar; 36(3):2127-34. PubMed ID: 25403884
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
29. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
[TBL] [Abstract][Full Text] [Related]
30. MAT1 facilitates the lung metastasis of osteosarcoma through upregulation of AKT1 expression.
Wang J; Ni J; Song D; Ding M; Huang J; Li W; He G
Life Sci; 2019 Oct; 234():116771. PubMed ID: 31421084
[TBL] [Abstract][Full Text] [Related]
31. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
[TBL] [Abstract][Full Text] [Related]
32. IRX1 hypomethylation in osteosarcoma metastasis.
Lu J; Wang J
Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
[No Abstract] [Full Text] [Related]
33. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
[TBL] [Abstract][Full Text] [Related]
34. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
Denny SK; Yang D; Chuang CH; Brady JJ; Lim JS; Grüner BM; Chiou SH; Schep AN; Baral J; Hamard C; Antoine M; Wislez M; Kong CS; Connolly AJ; Park KS; Sage J; Greenleaf WJ; Winslow MM
Cell; 2016 Jul; 166(2):328-342. PubMed ID: 27374332
[TBL] [Abstract][Full Text] [Related]
35. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
37. CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma.
Wang W; Song H; Liu J; Song B; Cao X
DNA Cell Biol; 2011 Nov; 30(11):925-9. PubMed ID: 21563968
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
39. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
[TBL] [Abstract][Full Text] [Related]
40. miR-19a-mediated downregulation of RhoB inhibits the dephosphorylation of AKT1 and induces osteosarcoma cell metastasis.
Zou Q; Xiao X; Liang Y; Peng L; Guo Z; Li W; Yu W
Cancer Lett; 2018 Aug; 428():147-159. PubMed ID: 29702193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
